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Deep brain stimulation of the subthalamic nucleus (STN-DBS) in patients with Parkinson’s disease (PD) aﬀects speech
inconsistently. Recently, stimulation of the caudal zona incerta (cZi-DBS) has shown superior motor outcomes for PD patients,
but eﬀects on speech have not been systematically investigated. The aim of this study was to compare the eﬀects of cZi-DBS and
STN-DBS on voice intensity in PD patients. Mean intensity during reading and intensity decay during rapid syllable repetition
were measured for STN-DBS and cZi-DBS patients (eight patients per group), before- and 12 months after-surgery on- and oﬀ-
stimulation. For mean intensity, there were small signiﬁcant diﬀerences on- versus oﬀ-stimulation in each group: 74.2 (2.0)dB
contra 72.1 (2.2)dB (P = .002) for STN-DBS, and 71.6 (4.1)dB contra 72.8 (3.4)dB (P = .03) for cZi-DBS, with signiﬁcant
interaction (P<. 001). Intensity decay showed no signiﬁcant changes. The subtle diﬀerences found for mean intensity suggest that
STN-DBS and cZi-DBS may inﬂuence voice intensity diﬀerently.
1.Introduction
Deep brain stimulation (DBS) in the subthalamic nucleus
(STN) is an established and eﬀective treatment for motor
symptoms associated with Parkinson’s disease (PD). Eﬀects
ofSTN-DBSonspeechmotorfunction,however,arelesswell
deﬁned and have been reported either as variable [1]o ra sa n
a d v e r s es i d ee ﬀect of the stimulation [2]. Recently, the caudal
zona incerta (cZi) has been suggested as an alternative target
inPDtreatment[3,4].TheeﬀectsofcZi-DBSonspeechhave
not yet been reported in the literature. We have, therefore,
decided to evaluate its eﬀects on speech in conjunction with
an on-going study on surgical outcomes of cZi-DBS, and to
compare these with the eﬀects of STN-DBS.
Speech problems have been reported to occur in 70%
[5] and 89% [6] of PD patients at some stage during the
course of the disease, with higher prevalence as the disease
advances in its severity and/or its time course [7]. The
cardinalsymptomsofspeechdysfunctioninPD(hypokinetic
dysarthria) are weak voice, variable speech rate, short rushes
of speech, imprecise consonants, breathy and harsh voice,
and monotonous pitch. Of those symptoms, the perception
of weak voice has been corroborated by acoustic measures
of vocal intensity that demonstrate that PD patients have
reduced intensity compared with healthy controls [8].
Reducedintensityisassociatedwiththeearlystagesofspeech
deterioration in PD and is often severely aﬀected when
profound speech problems exist [9]. Studies have shown that2 Parkinson’s Disease
PD patients have lower mean voice intensity and limited
voice intensity range during normal conversation (see [10]
for a review) as well as faster intensity decay than controls
during vowel phonation and reading [11] and rapid syllable
repetition [12]. Problems with voice intensity in PD have
been attributed to the disease’s eﬀects on the respiratory
and phonatory systems, resulting in decreased respiratory
driveandincompleteclosureofthevocalfoldsduringspeech
production [10, 13].
Voice intensity plays a central role in the treatment of
speech problems associated with PD to the extent that “the
current primary focus in speech therapy for individuals
with hypokinetic dysarthria is vocal loudness” [10,p a g e
66]. The foremost example is the Lee Silverman Voice
treatment (LSVT) that has attained Class II level of evidence
for outcomes [14]. Considering the prominence of voice
intensity in speech deterioration and its treatment in PD, the
present study has focused on how it is aﬀected by DBS.
Ar e v i e wo fS T N - D B Sa st r e a t m e n tf o rP D[ 2]c i t e s
frequencies of 4–17% of cases with speech deterioration as
an adverse side eﬀect of stimulation. Studies that have sys-
tematically studied speech outcomes in patients who have
undergone STN-DBS treatment for PD have found that
changes are variable from patient to patient and dependent
on which speech features have been measured [15–29]. It
is evident from those reports that STN-DBS aﬀects speech
features much less than it does limb and nonaxial motor
symptoms, and recent results have suggested that DBS
diﬀerentially aﬀects the speech subsystems [25]. Despite the
lack of consistent ﬁndings regarding eﬀects of STN-DBS on
speech “the diﬀuse clinical impression is that speech may
often worsen after DBS” [15, page 366].
Studiesthathavespeciﬁcallyreportedvoiceintensityout-
comes following STN-DBS [15, 17, 23–26]a l lu s ed i ﬀerent
speech tasks and diﬀerent types of measures (acoustic or
perceptual), with varying followup durations after surgery,
making it diﬃcult to generalize ﬁndings on the eﬀects of
STN-DBS. However, regardless of diﬀerences in experimen-
tal detail, none of these studies has reported any statistically
signiﬁcant decrease of voice intensity as a stimulation eﬀect
of STN-DBS. Some have reported no signiﬁcant changes
[15, 17, 23], while others have found increases in mean
intensity [16, 24–26].
STN is currently the most frequent target of choice when
surgical treatment is employed for motor symptoms in PD.
H o w e v e r ,ar e c e n tr e p o r t[ 3] has suggested that stimulation
of the caudal zona incerta (cZi) may result in even better
limb motor outcomes. That study reported that cZi should
bestimulatedinpreferencetotherostralregion(rZi)inorder
to avoid the speech deterioration that was observed in some
patients for whom electrodes were located in the rZi region.
However, apart from a pilot study on perceptual speech
features associated with cZi-DBS [30], there are, to date,
no published reports that have systematically studied its
eﬀects on speech. It is important to investigate whether
stimulation of this alternate target can demonstrate not only
improved limb motor outcomes compared with STN-DBS,
but also whether it is able to avoid the detrimental speech
eﬀects that can be associated with STN-DBS. The aim of this
study was to compare eﬀects of cZi-DBS and STN-DBS on
voice intensity 12 months after surgery in patients with PD,
using two diﬀerent measures: mean voice intensity during
a reading task and voice intensity decline during a rapid
syllable repetition task.
2. Method
2.1. Patients. Sixteen consecutive patients (12 males and 4
females, aged between 49 and 72 years) with idiopathic PD
wereincludedinthisprospectivenon-randomisedstudy.The
ﬁrst eight patients had undergone STN-DBS (six bilateral
and two left-side unilateral) and the following eight cZi-
DBS (all bilateral). Seven of the eight patients in each group
also participated in an accompanying study on the eﬀects
of DBS on articulatory precision [31]. The patients had
been selected on clinical grounds for their suitability for
DBS surgery, and not on their speech status. The patients
were operated on between 2005 and 2007 (STN group) and
2008 and 2009 (cZi group). The clinical selection criteria for
the patients’ suitability for surgery were the same for both
groups. The surgical procedures for the respective targets
have been previously described in detail [3, 32]. An overview
of the patients is presented in Table 1. The study has been
approved by the Regional Ethical Review Board in Ume˚ a
(Dnr: 08-093M: 2008-08-18) and all examinations have been
conducted in accordance with local and national guidelines
for good clinical practice.
2.2. Speech Recording Procedure. The speech recordings
were coordinated with the patients’ scheduled neurological
examinations and were conducted on the morning of the
second day of an assessment protocol that extended over
two consecutive days. In the preoperative testing condition
(pre-op) the patients had undergone a levodopa challenge
and were medicated with 1.5 times their normal morning
dose. Testing was performed one hour after medication was
taken in a deﬁned on-state. The postoperative testing was
conducted at the time of the one year followup after surgery
(median 54 weeks after surgery, range 46–57 weeks) and
was performed in two conditions: one with stimulator oﬀ
for one hour before recording (oﬀ-stimulation) and one
with stimulator on for one hour before recording (on-
stimulation). The postoperative recordings were made in the
morning when the patients were medicated with their usual
postoperative dosage, which was less than preoperative levels
for all patients.
The recordings were made in a sound-treated booth,
using a head-mounted microphone (Sennheiser MKE 2 P-
C) that was calibrated using a purpose built calibration
system [33], with a 15cm mouth to microphone distance.
The samples were recorded at 48kHz sampling rate using a
digital audio ﬂash recorder (Marantz PMD 660) or in the
case of some early recordings a digital audio tape recorder
(Panasonic SV 3800). A calibration tone (80dB, 1kHz) was
used at the beginning of each recording.
Speech tasks selected from the recording protocol for this
study consisted of a standard 90 word Swedish reading pas-
sage (The Appendix), and rapid syllable repetition of threeParkinson’s Disease 3
Table 1: Characteristics of patients in the two surgical groups. There were no statistical diﬀerences between the groups for age, duration
since diagnosis, or any of the UPDRS scores.
Patient Uni/bilateral Gender Age at
operation (y)
Duration since
diagnosis (y)
UPDRS III Speech UPDRS III Item 18
Oﬀ med On med Oﬀ med On med
STN1 bi M 68 9 52 24 2 2
STN2 uni M 65 7 33 16 1 0
STN3 bi M 58 7 39 18 2 1
STN4 bi M 64 5 40 16 0 0
STN5 bi F 51 8 32 6 1 0
STN6 bi F 53 8 44 21 1 1
STN7 bi M 70 4 57 36 2 1
STN8 uni M 72 6 35 22 0 0
Median (range) 65 (51–72) 7 (4–9) 39.5 (32–57) 19.5 (6–36) 1.0 (0–2) 0.5 (0–2)
czI1 bi F 66 10 29 15 1 1
czI2 bi M 70 2 40 42 1 1
czI3 bi M 71 7 43 24 2 1
czI4 bi M 62 5 50 27 2 1
czI5 bi M 49 4 30 14 1 1
czI6 bi M 50 6 31 10 1 0
czI7 bi F 62 5 31 16 0 0
czI8 bi M 52 10 58 25 2 1
Median (range) 62.5 (49–71) 5.5 (2–10) 35.5 (29–58) 20.0 (10–42) 1.0 (0–2) 1.0 (0-1)
syllables /pΛpΛpΛ···/, /tΛtΛtΛ···/a n d/ k ΛkΛkΛ···/.
In the early recordings, the patients were instructed to
repeat each syllable sequence for as fast and for as long
as they could. In the more recent recordings, the person
conducting the test produced an auditory model of the task,
and the patients ﬁrst practised repeating the syllables evenly
at normal tempo, before proceeding to their fastest possible
tempo. Five STN patients received the earlier instructions
in all testing conditions, while six cZi patients received the
recent instructions in all conditions. The remaining three
STN and two cZi patients received the earlier instructions
for the preoperative test and the recent instructions for
postoperative tests.
2.3. Intensity Measures. Two intensity measures were made
from the recordings: average intensity during the reading
passage and the regression slope of intensity decay during
rapid syllable repetition. Intensity decay was calculated from
the rapid syllable repetition rather than the reading passage
because rapid syllable repetition has been found to be more
consistent in diﬀerentiating PD patients from controls [12].
Average voice intensity (dB SPL) for the reading passage for
eachpatientineachtestingconditionwasextractedusingthe
speech analysis software package Praat [34]. Intensity decay
(dB SPL per second) was deduced from the linear regression
slope of the intensity peaks in the vowels of consecutive
syllables in the syllable repetition task. The experimenters
who conducted the intensity measures (authors S. Lundgren
and T. Saeys) were blinded to the target and stimulation
conditions.
VoiceIntensityduringReading. Eachrecordingofthereading
passage was edited manually to remove extraneous non-
speech sounds. Then an automatic Praat script was used to
extract the intensity of every voiced frame of the passage.
Mean intensity over the whole passage was then deduced
from the individual frame measures.
Intensity Decay during Syllable Repetition. All syllable
sequences were examined to determine their suitability for
inclusion.Thecriterionforinclusionofasequencewasthatit
musthavebeenproducedwithinonebreath,andthatitmust
have consisted of at least eight measurable syllables, where
a syllable was deﬁned as measurable if it consisted of an
increase of energy followed by a period of silence or reduced
energy in the waveform [35]. Of a possible 144 sequences,
134 met the inclusion criteria. First and last syllables in each
eligible sequence were then excluded to avoid start and end
eﬀects. Linear regression of the maximum intensity of each
included syllable in the sequence against the time point for
that intensity peak was performed in order to calculate the
slope of the intensity decay. Finally, the intensity decay slopes
of the three syllable repetition tasks were averaged for each
patient in each testing condition.
The values reported are the group means of the intensity
decay slopes for each testing condition, based on sequences
of eight or more repeated syllables. Ten of a possible 144
sequences were excluded because they were too short (eight
for one patient and two for another).
2.4. Reliability. For the reading passage, 50% of the samples
were measured by the two experimenters. All the computed4 Parkinson’s Disease
means were tested for interjudge reliability using Pearson
product-moment correlation statistics (Pearson’s r), and the
reliability wassigniﬁcant(r = 0.83–1.00, P<. 001). Allofthe
syllablerepetitionsequencesweremeasuredseparatelybythe
same two experimenters. The measured syllable’s time point
pairs for each sequence were manually compared to verify
that the correct syllables had been measured, and that the
syllables corresponded to the syllable deﬁnition. Reliability
tests using Pearson’s r on the syllable intensities for 10% of
the sequences showed that reliability was signiﬁcant (r =
0.99, P<. 001).
2.5. Statistical Analysis. Between- within analyses of variance
(ANOVA) and post hoc t-testing were used to test for on-oﬀ
stimulation as well as long-term stimulation eﬀects of cZi-
DBS and STN-DBS.
3. Results
3.1. Voice Intensity during Reading. Figure 1 shows the group
means and standard deviations for voice intensity during
reading for the STN and the cZi groups in each of the three
testing conditions. Repeated measures ANOVA showed that
therewasasigniﬁcanteﬀectfortestingconditionfortheSTN
group (F (2,14) = 5.135, P = .02) but not for the cZi group
(F (2,14) = 2.147, P = .154).
Oﬀ- versus on-Stimulation. I tc a nb es e e nf r o mFigure 1
that the eﬀects of stimulation on mean intensity during
readingareindiﬀerentdirectionsforthetwogroups,withan
increase in intensity on-stimulation in the STN group and a
decreaseon-stimulationforthecZigroup.Additionally,atan
individuallevel,alleightSTN-DBSpatientsshowedthesame
pattern between oﬀ- and on-stimulation testing conditions,
as did seven of eight cZi-DBS patients (see Figure 2). Paired
t-testing revealed that for the STN group the on-stimulation
mean (74.2 ± 2.0dB) was signiﬁcantly larger than oﬀ-
stimulation (72.1 ± 2.2dB; t(7) = 4.638, P = .002), while for
the cZi group the on-stimulation mean (71.6 ± 4.1dB) was
signiﬁcantly less than oﬀ-stimulation (72.8 ± 3.4dB; t(7) =
2.697, P = .03). A between-within ANOVA conﬁrmed that
the interaction eﬀect between group and testing condition
was signiﬁcant (F(1,14) = 27.258, P<. 001).
Long-Term Stimulation Eﬀects. Diﬀerences between the pre-
operative and the two postoperative testing conditions were
examined for each group. It can be seen from Figure 1 that
in each group the preoperative and on-stimulation mean
intensities were very similar, and paired t-tests conﬁrmed
thatthere wereno statistically signiﬁcant diﬀerences between
those conditions for either group. For the STN group,
the mean intensity in the oﬀ-stimulation condition was
signiﬁcantly less than in the preoperative condition (72.1dB,
74.0dB; t(7) = 2.485, P = .04). There was, however, no
signiﬁcant diﬀerence between the mean intensities for those
two conditions for the cZi group (71.3dB, 72.8dB; t(7) =
−1.857, P = .106).
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Figure 1: Voice intensity during reading for the STN and cZi
groups, respectively, showing means and standard deviations for
preoperative and postoperative oﬀ- and on-stimulation testing
conditions.
3.2. Intensity Decay during Syllable Repetition. Figure 3
shows the mean intensity decay slopes for each group in each
condition. There was no overall signiﬁcance of condition
for either group, nor were there any signiﬁcant diﬀerences
between on- and oﬀ-stimulation testing conditions, or
between preoperative and either postoperative condition.
There was a high degree of individual variation within the
groups that can be seen in Figure 4. For the STN group,
four of the eight patients followed the trends for all three
conditionsshowninthegroupdatawhileforinthecZigroup
only two of the eight patients had trends consistent with
the group means. When comparing on- with oﬀ-stimulation
testing conditions, ﬁve patients in the STN group had a
shallower decline of voice intensity while for the cZi group
ﬁve patients had a steeper decline.
4. Discussion
ThisstudyistheﬁrsttoreporttheeﬀectsofcZi-DBSonvoice
intensity in Parkinson’s disease and compare them to eﬀects
of STN-DBS. Stimulation 12 months after surgery was inves-
tigated by comparing on- with oﬀ-stimulation conditions
on the same day, while longer-term eﬀects of surgery were
studied by comparing the 12 months postoperative testing
conditions with the preoperative condition.
For on- versus oﬀ-stimulation 12 months after surgery,
mean voice intensity during reading changed for both
S T Na n dc Z ig r o u p s ,b u ti nd i ﬀerent directions. The STN
group showed an increase of 2.1dB while the cZi group
showed a reduction of 1.15dB. Both results were statistically
signiﬁcant. The results at individual patient level were also
notably consistent with the group result for all eight STN
and 7 of 8 cZi patients. The results for intensity decay, on
the other hand, were not signiﬁcant for testing condition
in either group and showed a high degree of individual
variability for patients in both groups. The minor diﬀerence
in the syllable repetition task instructions with a lack of a
practice model mainly for the STN-DBS patients is unlikelyParkinson’s Disease 5
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Figure 2: Mean intensity during reading for individual patients in STN and cZi groups.
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Figure 3: Syllable intensity decay (dB/s) for the STN and cZi
groups respectively, showing means and standard deviations for
preoperative and postoperative oﬀ- and on-stimulation testing
conditions.
to be the source of this variability since the results for the cZi
group were equally or even more variable.
The small statistically signiﬁcant increase in mean inten-
sity on-stimulation for the STN group in our study is
consistent with one other report of a group of seven PD
patients who had undergone STN-DBS. Dromey et al. [16]
found a signiﬁcant voice intensity increase of 1.1dB in re-
sponse to stimulation during a monologue speech task 6
months after surgery when the patients were in their medi-
cated state. Like our study, the diﬀerence was also consistent
at individual patient level.
The diﬀerence in the response of voice intensity to
stimulation between the two groups of patients in our study
is unlikely to have been due to preoperative diﬀerences.
At the time of surgery, the two groups did not diﬀer sig-
nificantly with regard to age, duration of disease since
diagnosis, UPDRS III scores, or speech status according to
UPDRS III Item 18 scores (Table 1) and preoperativedB
(SPL)(Figure 1).Itshould,however,benotedthattherewere
two patients with left-side unilateral stimulation in the STN
group. Lateralisation eﬀects of STN-DBS on various aspects
of speech have been found [23, 26, 27], but the inspection
of individual results for voice intensity in the current study
(Figures 3 and 4) revealed no diﬀerences for the unilateral
patients. Additionally, excluding the unilateral patients from
the statistical analysis did not alter the statistical signiﬁcance
of any result.
It should be noted that the postoperative speech record-
ings in the current study were made when the patients were
medicated at their usual postoperative dose levels. Since PD
patientswhohaveundergoneDBSgenerallystilltakereduced
doses of medication following surgery for best clinical
outcome, testing with medication reﬂects their usual clinical
status. Studies of DBS eﬀects should preferably involve a
medication-oﬀ state to capture the eﬀects of stimulation
alone as well as a medication-on state so that the usual
clinicalstateisreﬂectedintheexperimentaldesign.However,
such a design necessitates testing patients when they are
oﬀ-stimulation and without medication, a condition which
involves considerable discomfort. Thus, we elected to test
the patients only in the medicated conditions because we
needed to consider carefully their limited availability for
testing and their well being during that time. We would
also have risked some patients being unable or declining to
participate further in the study which could potentially have
biased our longitudinal data collection.
Studies that have reported results from all four testing
conditions [15, 16, 22] may allow us to infer the eﬀects
of medication status when stimulation eﬀects are being
investigated. The ﬁndings are, however, not consistent.
Smallerchangeswerefoundtobeassociatedwithstimulation
when patients were medicated than when not medicated in
two studies [15, 22]. Dromey et al. [16], on the other hand,6 Parkinson’s Disease
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Figure 4: Intensity decay during syllable repetition for individual patients in STN and cZi groups.
found larger and more consistent changes with stimulation
when patients were medicated. This inconsistency between
studies is perhaps to be expected when one considers that
studies of the eﬀects of medication alone on speech in PD
patients who are being treated pharmacologically are not
conclusive, for example, [36–38]. The results of the current
study have only been compared with studies that include
equivalent testing conditions.
While the diﬀerences in mean intensity between on- and
oﬀ-stimulation conditions in both groups were found to be
statistically signiﬁcant, they were small, which is possibly
because preoperatively there were only mild speech eﬀects
due to the disease. The magnitude of the diﬀerences for both
groups is likely to be borderline for any clinical signiﬁcance
and it will be important to conﬁrm this with a listening
study in the future. While clinical signiﬁcance is of utmost
importance for the prognosis of the operation, subclinical
diﬀerences may still have implications for understanding the
eﬀects of treatment on speech motor control.
Long-term eﬀects of stimulation 12 months after surgery
were studied by comparing preoperative and postoperative
conditions. There was just one statistically signiﬁcant result:
a decrease in voice intensity during reading from the
preoperative to the postoperative oﬀ-stimulation condition
for STN-DBS, whereas for cZi-DBS there was a small but
nonsigniﬁcant increase. The group means for voice intensity
for postoperative on-stimulation testing conditions were
very similar to the preoperative condition for both groups,
with no statistically signiﬁcant diﬀerences between those
conditions. Measures of intensity decay were highly variable
across patients and gave no statistically signiﬁcant results.
Our ﬁndings for long-term eﬀects of STN-DBS on voice
intensity contrast with those of Tripoliti et al. [25]. That
study on a group of 32 STN-DBS patients reported a 7.4dB
increase in intensity during reading between preoperative
and 12 months postoperative on-stimulation testing condi-
tions when the patients were medicated.
It should be noted that the patients in our study had
been subjected to a levodopa challenge for the preoperative
test condition where their medication dosage was 1.5 times
higher than usual.They were, however, all tested during their
deﬁned on-state. Thus the results of the long-term eﬀects
of stimulation need to be interpreted with some caution.
However, if the decrease from preoperative to postoperative
oﬀ-stimulation testing conditions for the STN group were
to be explained by the fact that the preoperative medication
dose was higher than the usual dosage, then the same ﬁnding
should be expected for the cZi group, but this was not the
case. However, before one could explain the diﬀerence as a
long-termsurgicaleﬀectthatdiﬀersbetweenthetwosurgical
targets, larger group sizes will be required to conﬁrm the
ﬁnding.
In summary, the most notable ﬁndings in our com-
parison of the eﬀects of cZi-DBS with STN-DBS for PD
patientsweresmallon-oﬀstimulationdiﬀerencesindiﬀerent
directionsformeanvoiceintensityduringreading12months
after surgery. While the magnitudes of the diﬀerences were
small, they were statistically signiﬁcant and their consistency
at individual patient level is noteworthy. Measures related
to the underlying physiological responses could be used to
determine if these changes are reﬂected in the respiratory
system and vocal fold adduction, both of which can result
in changes to vocal intensity. A recent study on the eﬀects
of STN-DBS on respiratory measures [13] has showed
considerable interpatient variability for measures that reﬂect
respiratory drive and degree of vocal fold adduction. While
respiratory measures for patients in the current study were
not recorded, it will be possible to further investigate theirParkinson’s Disease 7
vocal fold adduction and intensity changes during sus-
tained vowel phonation using recordings from transnasal
laryngoscopic and electroglottographic recordings that were
made as part of the larger recording battery.
5. Conclusion
This study investigated eﬀects on voice intensity of cZi-DBS,
a recently proposed alternative to STN-DBS as a surgical
treatment of PD, and compared them with those found for
STN-DBS. The results showed that the stimulation response
of mean voice intensity during reading was diﬀerent for cZi-
DBS compared with STN-DBS for two groups with eight
patients in each. While the magnitudes of the diﬀerences for
group means were small, the responses at individual patient
level were remarkably consistent. The subtle diﬀerences
found for mean intensity suggest that STN-DBS and cZi-
DBS may inﬂuence voice intensity diﬀerently. A related
study that used essentially the same patient groups has also
shownadiﬀerentialresponsebetweencZi-andSTN-DBSfor
articulatory proﬁciency [31]. It will be important to conﬁrm
these diﬀerential eﬀects and their consistency at individual
level in studies with larger patient numbers.
Appendix
Reading passage
En pojke kom en dag inspringande p˚ ae n
bondg˚ ard och undrade om han kunde f˚ al˚ ana en
spade. Bonden fr˚ agade vad han skulle ha spaden
till. Pojken svarade att hans bror hade ramlat i
ett tr¨ a s ko c hh a nm˚ aste gr¨ ava upp honom. “Hur
djupt har han ramlat i?” fr˚ agade bonden. “Upp
till vristerna”, blev svaret. “Men d˚ ah a nk a nv ¨ al
g˚ ad ¨ arifr˚ an utan din hj¨ alp s˚ ad ˚ ab e h ¨ over du v¨ al
ingen spade?” Pojken s˚ ag f¨ ortvivlad ut och sa:
“Jo, men ni f¨ orst˚ ar, han ramlade i med huvudet
f¨ ore.” (Ett sv˚ art fall)
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